Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

NCT00036556 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00036556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
Not reported
Enrollment
941 (actual)
Sites
234

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms